Statistics

Total Visits

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study53

Select a period of time:

Number of views in the range

Views
Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study37

Views

Views
March 202515
April 202512
May 20251
June 20250
July 20257
August 20250
September 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Hong Kong10
Brazil5
United States3
Ecuador1
Spain1
United Kingdom1
Mexico1
 

Top cities views

Views
Hong Kong10
Brasília1
Council Bluffs1
Curitiba1
Guarantã do Norte1
Guayaquil1
Kearny1
São Paulo1
Tijuana1
Torquay1